These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16550700)

  • 61. Do we need new antiemetic guidelines?
    Roila F
    Support Care Cancer; 2002 Oct; 10(7):517-8. PubMed ID: 12324804
    [No Abstract]   [Full Text] [Related]  

  • 62. A pilot study of a relaxation technique for management of nausea and vomiting in patients receiving cancer chemotherapy.
    Campos de Carvalho E; Martins FT; dos Santos CB
    Cancer Nurs; 2007; 30(2):163-7. PubMed ID: 17413783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [With evidence-based phytotherapy. Takes away gastric and intestinal irritation].
    MMW Fortschr Med; 2003 Mar; 145(13):57. PubMed ID: 15101542
    [No Abstract]   [Full Text] [Related]  

  • 65. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
    Nieber K; Schoppmeyer K
    Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144
    [No Abstract]   [Full Text] [Related]  

  • 66. Anti-emetic therapy: updating urological cancer-care providers.
    Pietrzak P; Arya M; Patel HR
    BJU Int; 2006 Apr; 97(4):673-5. PubMed ID: 16536750
    [No Abstract]   [Full Text] [Related]  

  • 67. NCCN antiemesis practice guidelines.
    Oncology (Williston Park); 1997 Nov; 11(11A):57-89. PubMed ID: 9430179
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacology. Counteracting side-effects.
    Donovan A
    Nurs Mirror; 1985 Oct; 161(14):38-9. PubMed ID: 2995930
    [No Abstract]   [Full Text] [Related]  

  • 69. Locally derived clinical practice guidelines using a decision analysis model.
    Mutnick AH; Szymusiak-Mutnick BA
    AACN Clin Issues; 1996 Aug; 7(3):448-55. PubMed ID: 8826406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients.
    Molassiotis A; Helin AM; Dabbour R; Hummerston S
    Complement Ther Med; 2007 Mar; 15(1):3-12. PubMed ID: 17352966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evolving paradigms in chemotherapy-induced nausea and vomiting and symptom management for the breast cancer patient.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):9-10. PubMed ID: 17824543
    [No Abstract]   [Full Text] [Related]  

  • 72. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1143-5. PubMed ID: 16632163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
    Mallik S; Palaian S; Ojha P; Mishra P
    Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of a scheduled IV cocktail of antiemetics for the palliation of nausea and vomiting in a hospice population.
    Kumar G; Hayes KA; Clark R
    Am J Hosp Palliat Care; 2008; 25(3):184-9. PubMed ID: 18573994
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The management of vomiting due to chemotherapy.
    Zulkhairi ; Kar AS
    Acta Med Indones; 2004; 36(4):219-26. PubMed ID: 15931721
    [No Abstract]   [Full Text] [Related]  

  • 77. Controlling emesis: what is it worth?
    Fox SC
    J Clin Oncol; 2006 Dec; 24(35):5617; author reply 5616-7. PubMed ID: 17158553
    [No Abstract]   [Full Text] [Related]  

  • 78. Symptom control, treatment-induced nausea prophylaxis, and palliative radiation therapy.
    Simone CB
    Ann Palliat Med; 2018 Apr; 7(2):E2-E4. PubMed ID: 29764180
    [No Abstract]   [Full Text] [Related]  

  • 79. Palliative care. Nausea and vomiting.
    Kinghorn S
    Nurs Times; 1997 Aug 13-19; 93(33):57-60. PubMed ID: 9335885
    [No Abstract]   [Full Text] [Related]  

  • 80. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.